Icahn has sold his shares in the company over concerns at China’s influence on its stock price
Billionaire activist investor Carl Icahn says he had sold his entire stake in Apple Inc, citing the risk of China’s influence on the stock.
In an interview with US cable television network CNBC on Thursday, Icahn also said he was “still very cautious” on the US stock market and there would be a “day of reckoning” unless there was some sort of fiscal stimulus.
Icahn had been a huge cheerleader of Apple, acquiring a stake in the company almost three years ago, repeatedly calling the investment a “no brainer.”
In an open letter to Apple chief executive Tim Cook in May 2015, Icahn had argued that shares of the iPhone maker were worth $240 (£164), about 90% more than they had been trading. At $240 a share, Apple’s market cap would be $1.4tn, Icahn asserted.
But Icahn, who owned 45.8m Apple shares at the end of last year, said China’s economic slowdown and worries about how China could become more prohibitive in doing business triggered his decision to exit his position entirely.
Published By - Theguardian.com - Sports New, LifeStyle News, Politics news, UK and world political comment and analysis: Friday 29 April 2016 01.13 BST
View the latest news and breaking news today for U.S., world, weather, entertainment, politics and health at theNews Linzer
Subscribe to:
Post Comments (Atom)
Featured post
Marvel executive says emphasis on diversity may have alienated readers
Marvel’s vice president of sales has blamed declining comic-book sales on the studio’s efforts to increase diversity and female char...
-
An Overview Guide to Leather Grades In the world of heritage/reproduction products with a focus on quality and sustainability, leathe...
-
Monarch heard accusing Chinese officials of being rude to ambassador in connection with President Xi’s state visit last year China has...
-
Ankara, the capital of Turkey, in the crazily area of a huge explosion as a result of which the number of casualties that is 34 while the 12...
No comments:
Post a Comment